ISRCTN15396562已完成未知
Multicenter Uveitis Steroid Treatment Trial
The Multicenter Uveitis Steroid Treatment Trial (MUST) Coordinating Center (USA)0 个研究点目标入组 250 人开始时间: 2007年8月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
- 2010 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/20097325 2. 2015 results in: https://www.ncbi.nlm.nih.gov/pubmed/26359188
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Age 13 years or older
- •2. Best-corrected visual acuity of hand motions or better in at least one eye with uveitis
- •3. Intraocular pressure 24 mmHg or less in all eyes with uveitis
排除标准
- •1. Inadequately controlled diabetes
- •2. Uncontrolled glaucoma
- •3. Advanced glaucomatous optic nerve injury
- •4. A history of scleritis; presence of an ocular toxoplasmosis scar
- •5. HIV infection or other immunodeficiency disease for which corticosteroid therapy would be contraindicated according to best medical judgment
研究者
相似试验
进行中（未招募）
1 期
Multicenter Uveitis Steroid Treatment Trial - MUSTon-infectious uveitis (inflammatory eye disease)MedDRA version: 9.1 Level: LLT Classification code 10046851 Term: UveitisMedDRA version: 9.1 Level: LLT Classification code 10033687 Term: PanuveitisMedDRA version: 9.1 Level: LLT Classification code 10022557 Term: Intermediate uveitisMedDRA version: 9.1 Level: LLT Classification code 10036370 Term: Posterior uveitisEUCTR2007-003612-53-GBational Institutes of Health, National Eye Institute250
已完成
4 期
Multicenter Uveitis Steroid Treatment (MUST) TrialUveitisNCT00132691JHSPH Center for Clinical Trials255
进行中（未招募）
4 期
Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)UveitisNCT05180526Bio-Thera Solutions60
已完成
2 期
Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)UveitisNCT02911116National Eye Institute (NEI)8
撤回
1 期
Ustekinumab for Active Sight-Threatening UveitisUveitisNCT01647152National Eye Institute (NEI)